BIND Therapeutics: Annual Report 2014 (BIND Therapeutics) - Mar 13, 2015 - “In January 2015, we also announced positive topline data from the ongoing Phase 2 trial in mCRPC; however, given the rapidly emerging treatment landscape in mCRPC we have decided not to move forward with the development of BIND-014 in mCRPC and focus our resources on more promising opportunities”
Discontinued • Oncology • Prostate Cancer
|